跳至主要内容
临床试验/IRCT20190717044241N1
IRCT20190717044241N1招募中1 期

Cell therapy using human-derived placental-derived mesenchymal stem cells in patients with Acute liver failure: clinical trial phase I

Tehran University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 no limit(—)
性别
All

入选标准

  • ALF: The occurrence of hepatic encephalopathy is less than 8 weeks after the onset of jaundice in a disease that does not have a history of known liver disease.
  • All patients with ALF or ACLF are admitted to hospital at Shariati Hospital and Imam Khomeini Hospital.

排除标准

  • Patient dissatisfaction
  • Pregnant patient
  • Age less than 17 years
  • Patient with known active malignancy

研究者

相似试验